Biloba Kessel-LO SRL
Biloba Kessel-LO reported total assets of 611,082 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Biloba Kessel-LO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biloba Kessel-LO's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 33,798 € | ||||
| Equity | 14,734 € | ||||
| Cash | 52,756 € | ||||
| EBITDA | 69,923 € | ||||
| Total assets | 611,082 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 09 Sep 2022
Biloba Kessel-LO's financial analysis
- Solvency2.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biloba Kessel-LO
Biloba Kessel-LO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.341.212
- VAT number
- BE0471341212
- Peppol
- Registered · 0208:0471341212 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Mar 2000
- Registered office
- 3010 Leuven
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Biloba Kessel-LO (SRL) has been based in Leuven since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,798 € and equity of 14,734 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biloba Kessel-LO
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Haghedooren - Pelgroms Retail sale of pharmaceutical products Leuven · balance sheet 410,561 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Visa Pharma Retail sale of pharmaceutical products Chaudfontaine · balance sheet 615,498 €
- Pharmacie Thiry Anne Retail sale of pharmaceutical products Court-Saint-Étienne · balance sheet 628,009 €
- ML Pharma Retail sale of pharmaceutical products Brussels · balance sheet 573,903 €
- P.J. VLEUGELS et Cie Retail sale of pharmaceutical products Frameries · balance sheet 558,880 €
- Anglopharma Retail sale of pharmaceutical products De Panne · balance sheet 669,817 €
- LNR Retail sale of pharmaceutical products Kasterlee · balance sheet 516,544 €
Frequently asked questions about Biloba Kessel-LO
What is the revenue of Biloba Kessel-LO?
Biloba Kessel-LO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biloba Kessel-LO?
In Belgium, the VAT number is the company number prefixed with BE: BE0471341212 for Biloba Kessel-LO, if the company is VAT-registered. Its company number (CBE) is 0471.341.212.
Where is the registered office of Biloba Kessel-LO?
According to the CBE register, the registered office of Biloba Kessel-LO is in 3010 Leuven.
What is the equity of Biloba Kessel-LO?
At the close of the 2025 financial year, the equity of Biloba Kessel-LO amounts to 14,734 €, a solvency of 2.4% of total assets.
Who manages Biloba Kessel-LO?
The register lists 4 active mandates at Biloba Kessel-LO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biloba Kessel-LO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →